您当前的位置：
首页 >
文章列表页 >
Comprehensive clinical evaluation of phosphate-lowering drugs in the treatment of chronic kidney disease with hyperphosphatemia
更新时间：2026-07-28

    • Comprehensive clinical evaluation of phosphate-lowering drugs in the treatment of chronic kidney disease with hyperphosphatemia

    • ZHONGGUO YAOFANG   Vol. 37, Issue 14, Pages: 1918-1924(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.14.20    

      CLC： R969;R692

    • Received：16 March 2026，

      Revised：2026-05-18，

      Accepted：08 July 2026，

      Online First：24 July 2026，

      Published：30 July 2026

    移动端阅览

  • LIU Lu,SONG Cangsang,LI Xingde,et al.Comprehensive clinical evaluation of phosphate-lowering drugs in the treatment of chronic kidney disease with hyperphosphatemia[J].ZHONGGUO YAOFANG,2026,37(14):1918-1924. DOI： 10.6039/j.issn.1001-0408.2026.14.20.

  •  
  •  

0

Views

7

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Analysis of influencing factors affecting the efficacy of Shenfukang capsule in the treatment of chronic kidney disease and construction of prediction model
Study on the mechanism of cordycepin inhibiting ferroptosis via the Nrf2/HO-1 pathway to delay the transformation from AKI to CKD
氢氧化镧对大鼠慢性肾衰高磷血症的改善作用研究
碳酸镧治疗尿毒症维持性血液透析患者高磷血症的临床观察
碳酸司维拉姆联合常规治疗对慢性肾衰竭合并高磷血症患者血清炎症因子及HO-1、iPTH水平的影响

Related Author

ZHONG Xiaobin
LIANG Zhiwei
ZOU Xiaoqin
YANG Yufang
QIN Mengyuan
TANG Li
ZHOU Xiaoshuang
ZHAO Zhibo

Related Institution

Dept. of Pharmacy， Guangxi Medical University Cancer Hospital
Dept. of Pharmacy， the First Affiliated Hospital of Guangxi Medical University
Dept. of Scientific Research， The First Affiliated Hospital of Guangxi Medical University
The Third Clinical College，Shanxi University of Chinese Medicine
Dept. of Nephrology，Shanxi Provincial People’s Hospital
0